Guardant Health
GH
#3559
Rank
HK$24.06 B
Marketcap
HK$195.58
Share price
-1.18%
Change (1 day)
-8.80%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of June 2024 : HK$8.06 B

According to Guardant Health 's latest financial reports the company has HK$8.06 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$9.12 B15.52%
2022-12-31HK$7.90 B8.64%
2021-12-31HK$7.27 B-47.74%
2020-12-31HK$13.91 B241.77%
2019-12-31HK$4.07 B24.12%
2018-12-31HK$3.28 B89.73%
2017-12-31HK$1.72 B134.09%
2016-12-31HK$0.73 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$6.91 B-14.31%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.33 B-83.49%๐Ÿ‡บ๐Ÿ‡ธ USA